Ashton Thomas Private Wealth LLC Cuts Position in The Clorox Company (NYSE:CLX)

Ashton Thomas Private Wealth LLC lessened its holdings in The Clorox Company (NYSE:CLX) by 9.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,089 shares of the company’s stock after selling 710 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Clorox were worth $1,085,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of CLX. Federated Hermes Inc. boosted its holdings in shares of Clorox by 16.4% during the 3rd quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock worth $622,000 after purchasing an additional 670 shares during the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Clorox by 5.6% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,096 shares of the company’s stock worth $406,000 after purchasing an additional 165 shares during the last quarter. Adage Capital Partners GP L.L.C. acquired a new position in shares of Clorox during the 3rd quarter worth approximately $6,605,000. Seven Eight Capital LP boosted its holdings in shares of Clorox by 75.2% during the 3rd quarter. Seven Eight Capital LP now owns 10,488 shares of the company’s stock worth $1,375,000 after purchasing an additional 4,503 shares during the last quarter. Finally, Schroder Investment Management Group boosted its holdings in shares of Clorox by 335.8% during the 3rd quarter. Schroder Investment Management Group now owns 279,669 shares of the company’s stock worth $36,653,000 after purchasing an additional 215,494 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.4 %

NYSE:CLX traded up $0.47 during trading hours on Friday, hitting $132.93. The company’s stock had a trading volume of 168,182 shares, compared to its average volume of 1,245,605. The stock has a market capitalization of $16.51 billion, a P/E ratio of 68.63, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. The stock has a fifty day moving average of $135.88 and a 200-day moving average of $143.52. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.51 earnings per share. On average, equities analysts forecast that The Clorox Company will post 5.91 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts recently commented on CLX shares. Argus upgraded Clorox to a “hold” rating in a report on Tuesday, June 4th. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a report on Tuesday, March 26th. Wells Fargo & Company decreased their price objective on Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Evercore ISI decreased their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Finally, BNP Paribas initiated coverage on Clorox in a report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price objective on the stock. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $145.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.